These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 6199120)
21. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Bitar DM; Whitacre CC Cell Immunol; 1988 Apr; 112(2):364-70. PubMed ID: 2451570 [TBL] [Abstract][Full Text] [Related]
22. T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis. Volovitz I; Mor F; Machlenkin A; Goldberger O; Marmor Y; Eisenbach L; Cohen IR Immunology; 2009 Sep; 128(1):92-102. PubMed ID: 19689739 [TBL] [Abstract][Full Text] [Related]
23. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis. Hilliard B; Ventura ES; Rostami A Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096 [TBL] [Abstract][Full Text] [Related]
24. Suppression of experimental allergic encephalomyelitis in the Lewis rat, by administration of an acylated synthetic peptide of myelin basic protein. St Louis J; Chan EL; Singh B; Strejan GH J Neuroimmunol; 1997 Mar; 73(1-2):90-100. PubMed ID: 9058764 [TBL] [Abstract][Full Text] [Related]
25. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4. Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533 [TBL] [Abstract][Full Text] [Related]
26. Chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs: cell-mediated immunity and IgG isoelectric focusing in myelin basic protein-liposome-treated and untreated animals. St Louis J; Gilbert JJ; Moscarello MA; Strejan GH J Neuroimmunol; 1989 Feb; 21(2-3):137-47. PubMed ID: 2463997 [TBL] [Abstract][Full Text] [Related]
27. Experimental allergic encephalomyelitis: clinical disease and enhanced cellular transfer in the absence of lymphocyte proliferative responses against syngeneic MBP. Hunter S Cell Immunol; 1986 Jan; 97(1):204-9. PubMed ID: 2427218 [TBL] [Abstract][Full Text] [Related]
28. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats. Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428 [TBL] [Abstract][Full Text] [Related]
29. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Bolton C; Allsopp G; Cuzner ML Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543 [TBL] [Abstract][Full Text] [Related]
30. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. Ishigami T; White CA; Pender MP Eur J Immunol; 1998 May; 28(5):1626-35. PubMed ID: 9603469 [TBL] [Abstract][Full Text] [Related]
31. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells. Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391 [TBL] [Abstract][Full Text] [Related]
32. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats. Willenborg DO; Higgins TJ Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel. Cao L; Sun D; Cruz T; Moscarello MA; Ludwin SK; Whitaker JN J Neuroimmunol; 2000 Aug; 108(1-2):103-11. PubMed ID: 10900343 [TBL] [Abstract][Full Text] [Related]
34. The role of regulatory T cells in Lewis rats resistant to EAE. Sun D; Wilson DB; Cao L; Whitaker JN J Neuroimmunol; 1998 Jan; 81(1-2):177-83. PubMed ID: 9521620 [TBL] [Abstract][Full Text] [Related]
35. The role of myelin lipids in experimental allergic encephalomyelitis. Part 2. Influence on disease production by encephalitogenic doses of myelin basic protein. Hosein ZZ; Gilbert JJ; Strejan GH J Neuroimmunol; 1986 Jan; 10(3):219-33. PubMed ID: 2416773 [TBL] [Abstract][Full Text] [Related]
36. Differential recognition of sequences within the encephalitogenic region of myelin basic protein capable of eliciting cell-mediated immune responses in experimental autoimmune encephalomyelitis. Malotky MK; Paterson PY; Miller SD J Neuroimmunol; 1993; 48(2):135-42. PubMed ID: 7693752 [TBL] [Abstract][Full Text] [Related]
37. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesions of EAE. Matsumoto Y; Fujiwara M J Neurol Sci; 1987 Jan; 77(1):35-47. PubMed ID: 2433404 [TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in rats. Inamura N; Hashimoto M; Nakahara K; Nakajima Y; Nishio M; Aoki H; Yamaguchi I; Kohsaka M Int J Immunopharmacol; 1988; 10(8):991-5. PubMed ID: 2463974 [TBL] [Abstract][Full Text] [Related]
39. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats. Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796 [TBL] [Abstract][Full Text] [Related]
40. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats. Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]